SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Trading Statement

30 Nov 2009 07:00

RNS Number : 2458D
Origin Enterprises Plc
30 November 2009
 



Trading Update

30 November 2009

 

This Trading Update relates to the three month period ended 31 October 2009.

Origin Enterprises plc ('Origin' or the 'Group') reports a performance in line with our expectations for the first quarter of the 2010 financial year. Reflecting the increased seasonality of the business approximately 20% of annual operating profits are typically earned in the first half of the financial year.

Highlights

Group revenue of €323.5 million, a decrease of 23.8%

Acquisitions completed in the second half of 2009 accounted for 3.3%

The transfer of our Marine Proteins business to Welcon accounted for (3.6%)

Currency accounted for (6.3%)

Reduction in underlying revenues of 17.2% principally due to the impact of lower commodity prices

EBITA* of €12.7 million for the first quarter compared with €21.2 million in the corresponding period last year 

* including share of profit after tax from associates and joint venture

Agri-Nutrition

The Agri-Nutrition division achieved revenues of €252.9m compared with €340.8m in the corresponding period last yearan underlying reduction of 17.5%. This reflects the impact of lower commodity prices and customers adopting a cautious approach to volume commitments in advance of the main application period. The Group's integrated agronomy services business, operating under Masstock in the United Kingdom and Dalgety in Poland, continues to perform well with forecasts for total arable plantings providing a positive platform for the full year performance from this business. 

Food

The Food division generated revenues of €70.6m compared with €83.9m in the corresponding period last year principally reflecting lower agency distribution activityFood has delivered a satisfactory performance against the background of continued weakness in consumer sentiment. Origin's consumer brands continue to demonstrate resilience and are well positioned in categories of consumer spending that are increasingly focused on staple food purchases. 

Joint Venture

The performance of Welcon, Europe's leading manufacturer of marine proteins and oils, is in line with expectations with satisfactory landings of raw material achieved in the period.

Outlook

Customers are adopting a wait and see approach in response to the current challenging environment for farming. The recent uplift in primary output markets, while welcome, has yet to positively impact farm incomes. Against this background we continue to maintain a cautious approach but remain comfortable with market expectations for the full year.

ENDS

Enquiries 

Brendan Fitzgerald

Chief Financial Officer

Origin Enterprises plc151 Thomas Street

Dublin 8

Murray Consultants 

Joe Murray 086 2534950

Pauline Dooley 01 4980300

Tel: +353 1 6121259

Fax: +353 1 6121333

About Origin Enterprises plc

Origin Enterprises plc is a leading Agri-Nutrition and Food company listed on the IEX and AIM markets of the Irish and London Stock Exchanges. The Agri-Nutrition division, through its manufacturing and distribution operations in Ireland, the United KingdomPoland and Norway, has leading market positions in the supply of feed ingredients, integrated agronomy services, crop nutrition and marine proteins and oils. The Group's Food division, comprising sales, marketing, distribution and manufacturing activities in Ireland, has leadership positions in ambient food across the retail, food service and manufacturing sectors.

IEX ticker symbol: OIZ

AIM ticker symbol: OGN

Website: www.originenterprises.com

All comments are based on unaudited management accounts. Certain statements made in this Trading Update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVDLFLKFBLFBD
Date   Source Headline
3rd Oct 202511:26 amRNSRe-issue of Treasury Shares
2nd Oct 20252:45 pmRNSRe-issue of Treasury Shares
1st Oct 20251:11 pmRNSRe-issue of Treasury Shares
1st Oct 20257:00 amRNSDirectorate Change
30th Sep 20252:58 pmRNSRe-issue of Treasury Shares
25th Sep 20254:02 pmRNSHolding(s) in Company
25th Sep 20254:02 pmRNSHolding(s) in Company
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSFinal Results
22nd Sep 20254:49 pmRNSRe-issue of Treasury Shares
26th Aug 20257:00 amRNSHolding(s) in Company
13th Aug 20255:11 pmRNSHolding(s) in Company
30th Jul 20254:31 pmRNSHolding(s) in Company
26th Jun 202511:23 amRNSCancellation of Treasury Shares
20th Jun 202512:27 pmRNSRe-issue of Treasury Shares
18th Jun 202512:51 pmRNSDirector/PDMR Shareholding
13th Jun 20255:09 pmRNSRe-issue of Treasury Shares
13th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSQ3 Trading Update
28th May 20254:18 pmRNSHolding(s) in Company
22nd May 20257:00 amRNSHolding(s) in Company
2nd May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20251:41 pmRNSDirector/PDMR Shareholding
29th Apr 20251:33 pmRNSDirector/PDMR Shareholding
29th Apr 20251:32 pmRNSDirector/PDMR Shareholding
24th Apr 20252:58 pmRNSHolding(s) in Company
9th Apr 202511:44 amRNSHolding(s) in Company
4th Apr 20253:34 pmRNSHolding(s) in Company
2nd Apr 20251:53 pmRNSHolding(s) in Company
25th Mar 20254:54 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSInterim Results Statement
28th Feb 20255:19 pmRNSHolding(s) in Company
26th Feb 20251:13 pmRNSHolding(s) in Company
25th Feb 20253:51 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSNew five-year €440 million credit facility
5th Feb 20256:12 pmRNSHolding(s) in Company
4th Feb 202511:52 amRNSRe-issue of Treasury Shares
31st Jan 20255:22 pmRNSLong Term Incentive Plan / PDMR Notification
31st Jan 20253:05 pmRNSRe-issue of Treasury Shares
30th Jan 20256:08 pmRNSDirector/PDMR Shareholding
30th Jan 20256:05 pmRNSLong Term Incentive Plan / PDMR Notification
27th Jan 20252:52 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:15 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSDirector/PDMR Shareholding
20th Jan 20252:14 pmRNSHolding(s) in Company
16th Jan 20255:13 pmRNSHolding(s) in Company
7th Jan 20252:55 pmRNSDirector/PDMR Shareholding
12th Dec 20242:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.